Long-Term Incentive Plans (Tables)

9 Months Ended

Sep. 30, 2022

Share-based Payment Arrangement [Abstract]

Schedule of assumptions used to calculate compensation expense

	September 30,	December 31,
	2022	2021
Expected volatility	4.16% - 4.26%	4.4% - 66.3%
Weighted-average volatility	35.4%	38.9%
Expected term (in years)	2 - 7	2 - 7
Risk-free rate	1.79% - 3.49%	.8% - 1.5%

Schedule of vested and non-vested stock options activities

The tables below show the outstanding options, restricted stock, and restricted stock units under the 2019 and 2020 Plans as of September 30, 2022, and December 31, 2021, respectively:

	September 30, 2022
	Stock Options Outstanding	Weighted Average Grant-Date Fair Value		Weighted Average Exercise Price
Nonvested stock options and restricted
stock unit awards at December 31, 2021	317,217	$	25.80	$	40.13
Options granted	88,367		8.18		15.65
Restricted stock units granted	18,718		—		—
Adjustment to prior year options granted	65,414		—		—
Vested	(19,950)		19.42		37.44
Forfeited	(185,828)		29.18		41.05
Ending Balance at September 30, 2022	283,938	$	17.22	$	34.14

	December 31, 2021
	Stock Options Outstanding	Weighted Average Grant-Date Fair Value		Weighted Average Exercise Price
Nonvested stock options and restricted
stock unit awards at December 31, 2021	100,972	$	22.91	$	34.70
Options granted	333,880		19.25		42.84
Restricted stock units granted	5,089		—		—
Vested	(85,957)		17.32		30.20
Forfeited	(36,767)		23.91		40.42
Ending Balance at December 31, 2021	317,217	$	25.80	$	40.13

(1) Restricted stock and restricted stock units do not have an exercise price.

Schedule of outstanding vested and non-vested stock options and restricted stock unit

		Weighted Average Exercise Price Per Share		Weighted Average Remaining Contractual Life (Years)
Outstanding, Non vested options	267,894	$	34.11	8.8
Outstanding, Vested options	25,826		34.41	6.9
Outstanding, Non vested restricted	16,044
Outstanding, Vested restricted	1,163
Outstanding at September 30, 2022	310,927	$	34.14	8.6

			Weighted Average Exercise Price Per Share	Weighted Average Remaining Contractual Life (Years)
Outstanding, Non vested options	379,488	$	38.51	9.8
Outstanding, Vested options	85,957		43.91	10.0
Outstanding, Non vested restricted	23,686		44.05	8.5
Outstanding, Vested restricted	-		-	-
Outstanding at December 31, 2021	489,131	$	38.62	9.2